3 completed, 2 terminated. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 5 | Completed 3, Terminated 2 |
Follow Gamida Cell ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL GDA-201 - Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Terminated | Gamida Cell ltd | 13 | 2022-07-05 | 2025-03-25 |
| Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies CordIn - Sickle Cell Disease, Thalassemia | Phase 1 / Phase 2 | Terminated | Gamida Cell ltd | 1 | 2016-04-04 | 2019-06-26 |
| Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM NiCord® - Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL) | Phase 1 / Phase 2 | Completed | Gamida Cell ltd | 36 | 2013-04-01 | 2020-10-22 |
| Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies NiCord - Sickle Cell Disease & Thalassemia | Phase 1 / Phase 2 | Completed | Gamida Cell ltd | 16 | 2012-09-01 | 2022-05-20 |
| Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies NiCord® - Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) | Phase 1 / Phase 2 | Completed | Gamida Cell ltd | 12 | 2010-11-01 | 2021-08-03 |
Anemia, Sickle Cell (2) · Hematologic Neoplasms (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Thalassemia (2) · Genetic Diseases, Inborn (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Niacinamide (1)
United States (5) · France (1) · Italy (1) · Netherlands (1) · Singapore (1) · Spain (1)
Joanne Kurtzberg, MD (2) · Mitchell Horwitz, MD (2) · Allistair Abraham, MD (1) · David Snyder, PhD (1) · Franco Locatelli, MD (1) · Jean-Hugues Dalle, MD (1) · Joel Brochstein, MD (1) · Patrick Stiff, MD (1)